6.05.20
7 min. read

Thanks to Apple, Alivecor goes more DTC. Part II: Software as a drug.

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Issue 055.

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote up how Welldoc became the first company to get its digital therapy a billing code like a drug. Next week I am open to ideas -- what should E&O dig into? Here's what's happening this week:

  • Meant to include this last week: In Issue 053 I wrote about an RCT focused on a coach-led intervention for depression and anxiety. Small detail, but I missed a step in the IP licensing daisy-chain. Here's how it should have read: "A startup called Actualize Therapy has licensed the intervention for commercialization from the researchers, who incorporated as Adaptive Health." I originally thought Adaptive was the licensee and not the licensor.
  • Striiv, which at one point tried to compete with Fitbit in the early fitness wearable market, looks to be going under finally. Its founding CEO
×

Recent Articles